0001562180-22-002429.txt : 20220308 0001562180-22-002429.hdr.sgml : 20220308 20220308090748 ACCESSION NUMBER: 0001562180-22-002429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220303 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AGARWAL SUNIL CENTRAL INDEX KEY: 0001616640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 22720507 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-03-03 false 0001770121 Sana Biotechnology, Inc. SANA 0001616640 AGARWAL SUNIL C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false EVP, Head of Development & CMO Stock Options (Right to Buy) 5.70 2022-03-03 4 A false 250000.00 0.00 A 2032-03-02 Common Stock 250000.00 250000.00 D The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter. /s/ James J. MacDonald, Attorney-in-Fact for Sunil Agarwal 2022-03-08